Bracco Imaging's BR55 Receives FDA Fast Track Designation for Crohn's Disease Bracco Imaging's BR55, a novel molecular imaging agent, has received Fast Track designation from the FDA for detecting inflammation in Crohn's disease.

Bracco Imaging's BR55 Receives FDA Fast Track Designation for Crohn's Disease #United_States #Milan #Crohn's_Disease #Bracco_Imaging #BR55